Comment on “Prognostic value of sentinel lymph node biopsy according to Breslow thickness for cutaneous melanoma”

Serigne Lo; Matthew Stodell; Richard A Scolyer; John F. Thompson

doi:10.1016/j.jaad.2018.07.068

Related publications

Article2011

Sentinel Lymph Node Biopsy in Patients With Thin Primary Cutaneous Melanoma

Rajmohan Murali, Lauren E. Haydu, Michael J. Quinn, Robyn P.M. Saw, Kerwin F. Shannon, Andrew J. Spillane, Jonathan R. Stretch, John F. Thompson, Richard A Scolyer

Article2009

Sentinel Lymph Node Biopsy in Pediatric and Adolescent Cutaneous Melanoma Patients

Robert Howman‐Giles, Helen M. Shaw, Richard A Scolyer, Rajmohan Murali, James S. Wilmott, Stanley W. McCarthy, Roger F. Uren, John F. Thompson

Article2022

Therapeutic Value of Sentinel Lymph Node Biopsy in Patients With Melanoma

Jessica S. Crystal, John F. Thompson, John Hyngstrom, Corrado Caracò, Jonathan S. Zager, Tiina Jahkola, Tawnya L. Bowles, Elisabetta Pennacchioli, Peter D. Beitsch, Harald J. Hoekstra, Marc Moncrieff, Christian Ingvar, Alexander C.J. van Akkooi, Michael S. Sabel, Edward A. Levine, Doreen M. Agnese, Michael A. Henderson, Reinhard Dummer, Rogerio I. Neves, Carlo Riccardo Rossi, John M. Kane, Steven D. Trocha, Frances C. Wright, David R. Byrd, Maurice Matter,

Article2008

Sentinel Lymph Node Biopsy for Melanoma: Aspects of Pathologic Assessment

Rajmohan Murali, John F. Thompson, Richard A Scolyer

Article2004

Sentinel Node Biopsy Provides More Accurate Staging Than Elective Lymph Node Dissection in Patients With Cutaneous Melanoma

Anna Doubrovsky, Johannes H. W. de Wilt, Richard A Scolyer, William H. McCarthy, John F. Thompson